Colorectal cancer screening: Why immunochemical fecal occult blood tests may be the best option
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-230X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Colorectal cancer screening: Why immunochemical fecal occult blood tests may be the best option ; volume:12 ; number:1 ; day:29 ; month:12 ; year:2012 ; pages:1-6 ; date:12.2012
BMC gastroenterology ; 12, Heft 1 (29.12.2012), 1-6, 12.2012
- Urheber
-
Flitcroft, Kathy L.
- Beteiligte Personen und Organisationen
-
Irwig, Les M.
Carter, Stacy M.
Salkeld, Glenn P.
Gillespie, James A.
SpringerLink (Online service)
- DOI
-
10.1186/1471-230X-12-183
- URN
-
urn:nbn:de:1111-201607156354
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:44 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Flitcroft, Kathy L.
- Irwig, Les M.
- Carter, Stacy M.
- Salkeld, Glenn P.
- Gillespie, James A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Comparison between an immunochemical fecal occult blood test and a Guaiac based fecal occult blood test in detection of adenomas and colorectal cancer
Evaluation of quantitative fecal immunochemical tests for detection of occult blood in stool for colorectal cancer screening
Prostaglandin E-major urinary metabolite versus fecal immunochemical occult blood test as a biomarker for patient with ulcerative colitis
Accuracy of H. pylori fecal antigen test using fecal immunochemical test (FIT)
The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design
Profiling small RNAs in fecal immunochemical tests: is it possible?
Potential for optimizing fecal immunochemical test-based colorectal cancer srcreening strategies
A huge inflammatory fibroid polyp: an unexpected finding after positive fecal immunochemical test
Fecal Immunochemical Test Positivity Thresholds: An International Survey of Population-Based Screening Programs
Improving Fecal Occult Blood Testing Compliance Using a Mailed Educational Reminder
Microbiota-based model improves the sensitivity of fecal immunochemical test for detecting colonic lesions
Adherence to fecal immunochemical test screening among adults at average risk for colorectal cancer
Comparison between an immunochemical fecal occult blood test and a Guaiac based fecal occult blood test in detection of adenomas and colorectal cancer
Evaluation of quantitative fecal immunochemical tests for detection of occult blood in stool for colorectal cancer screening
Prostaglandin E-major urinary metabolite versus fecal immunochemical occult blood test as a biomarker for patient with ulcerative colitis
Accuracy of H. pylori fecal antigen test using fecal immunochemical test (FIT)
The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design
Profiling small RNAs in fecal immunochemical tests: is it possible?
Potential for optimizing fecal immunochemical test-based colorectal cancer srcreening strategies
A huge inflammatory fibroid polyp: an unexpected finding after positive fecal immunochemical test
Fecal Immunochemical Test Positivity Thresholds: An International Survey of Population-Based Screening Programs
Improving Fecal Occult Blood Testing Compliance Using a Mailed Educational Reminder
Microbiota-based model improves the sensitivity of fecal immunochemical test for detecting colonic lesions
Adherence to fecal immunochemical test screening among adults at average risk for colorectal cancer
Comparison between an immunochemical fecal occult blood test and a Guaiac based fecal occult blood test in detection of adenomas and colorectal cancer
Evaluation of quantitative fecal immunochemical tests for detection of occult blood in stool for colorectal cancer screening
Prostaglandin E-major urinary metabolite versus fecal immunochemical occult blood test as a biomarker for patient with ulcerative colitis
Accuracy of H. pylori fecal antigen test using fecal immunochemical test (FIT)
The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design
Profiling small RNAs in fecal immunochemical tests: is it possible?
Potential for optimizing fecal immunochemical test-based colorectal cancer srcreening strategies
A huge inflammatory fibroid polyp: an unexpected finding after positive fecal immunochemical test
Fecal Immunochemical Test Positivity Thresholds: An International Survey of Population-Based Screening Programs
Improving Fecal Occult Blood Testing Compliance Using a Mailed Educational Reminder
Microbiota-based model improves the sensitivity of fecal immunochemical test for detecting colonic lesions